Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1981 participants.
Also called NCT05683301
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose other
- Phase
- Phase 4
- Enrolled
- 1,981 participants
- Registry
-
NCT05683301
-
- Other papers using this trial's data
- Comparison of dual therapies for hypertension treatment in India: a randomized clinical trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT05683301. Randomized; quadruple masking; primary purpose other. Start 2022-08-30 (actual); primary completion 2024-08-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India
- Acronym
- TOPSPIN
- Condition
- Primary Hypertension
- Intervention (Drug)
- Amlodipine + Perindopril
- Intervention (Drug)
- Perindopril + Indapamide
- Intervention (Drug)
- Amlodipine + Indapamide
- Lead sponsor
- Centre for Chronic Disease Control, India
- Collaborator
- All India Institute of Medical Sciences
- Collaborator
- Imperial College London
Record details
- Record id
cardio:ct-nct05683301- Content hash
b422c1552543afaf7b5c127a5a5c9737b267d68354d727598a407364709eadfd